Independent technical advisory for clean-tech initiatives, TEA/LCA screening, investment and commercialisation support.
Resolvent Global supports clean-tech teams, investors and project sponsors with TEA/LCA screening, assumptions review, CAPEX/OPEX assessment, technical risk visibility and commercialisation decision support.
Clean-tech initiatives often move toward grants, investment, partnerships or scale-up before the technical and commercial evidence is strong enough. Founders, funders and project sponsors need clear assumptions, realistic cost boundaries, sustainability framing, risk visibility and independent engineering review before committing resources.
We combine process engineering, TEA/LCA thinking, clean-tech translation and technical due diligence to review assumptions, clarify risks, define assessment boundaries and support stronger investment, grant or commercialisation decisions.
Define the initiative
Clarify technology, intended application, development stage, value proposition, boundary and decision objective.
Review assumptions and evidence
Assess technical evidence, operating assumptions, data quality, performance claims and uncertainties.
Screen TEA and LCA boundaries
Review techno-economic assumptions, CAPEX/OPEX drivers, LCA boundary and sustainability considerations.
Identify risks and readiness gaps
Map technical, commercial, scale-up, implementation and market-readiness risks.
Develop advisory outputs
Convert findings into assumptions register, risk register, TEA/LCA screen and recommendations.
Stronger assumptions
Clarify technical, economic and sustainability assumptions.
TEA/LCA visibility
Screen cost drivers, emissions boundaries and lifecycle implications.
Risk clarity
Identify technical, commercial and scale-up risks.
Investor readiness
Support clearer documentation for funders, partners and management.
Resolvent Global can help review TEA/LCA boundaries, assumptions, risks and commercialisation readiness before major decisions.